0001225208-20-004028.txt : 20200303 0001225208-20-004028.hdr.sgml : 20200303 20200303125507 ACCESSION NUMBER: 0001225208-20-004028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200228 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG JOHN D CENTRAL INDEX KEY: 0001551792 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 20680978 MAIL ADDRESS: STREET 1: C/O CORPORATE SECRETARY STREET 2: 235 EAST 42ND ST. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2020-02-28 0000078003 PFIZER INC PFE 0001551792 YOUNG JOHN D PFIZER INC.-CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 1 Group President Common Stock 2020-02-28 4 M 0 100548.0000 27.3700 A 504427.0000 D Common Stock 2020-02-28 4 F 0 23802.0000 33.4200 D 480625.0000 D Common Stock 2020-02-28 4 F 0 51943.0000 36.4500 D 428682.0000 D Common Stock 2170.0000 I By Rule 16b-3 Plan Common Stock 1522.0000 I By Trustee under the Pfizer Share Ownership Plan Stock Appreciation Rights 27.3700 2020-02-28 4 M 0 100548.0000 0.0000 D 2020-02-28 2020-02-28 Common Stock 100548.0000 0.0000 D The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Susan E. Grant, by power of atty., for John D. Young 2020-03-03